Skip to main content
Premium Trial:

Request an Annual Quote

Ambry, Kapa Bio Reach Deal on Exome Sequencing Assays

NEW YORK (GenomeWeb) – Ambry Genetics has chosen Kapa Biosystems' Kapa Hyper Prep Kits for Ambry's ExomeNext and ExomeNext-Rapid exome sequencing assays, the companies said this week.

Kapa's kits feature improved library yields, with up to 40 percent of input DNA converted to adapter-ligated library, as well as greater coverage uniformity and a streamlined workflow that requires 35 minutes of hands-on time and less than three hours of total workflow time, Ambry and Kapa said.

The ExomeNext and ExomeNext-Rapid assays are designed specifically for establishing neonatal, pediatric, and adult-onset diagnoses of disease. They sequence and analyze the protein-coding regions in the approximately 20,000 genes in the human genome that code for proteins, and sequence and screen for characterized mutations in the mitochondrial genome. Using Kapa's kits with the assays will allow researchers to discover more actionable mutations more quickly, the companies said.

Financial and other terms of the deal were not disclosed.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.